514
Views
229
CrossRef citations to date
0
Altmetric
Review

Leishmaniasis in humans: drug or vaccine therapy?

&
Pages 25-40 | Published online: 22 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (19)

Disha Tewari, Kalpana Rawat, Amisha Bisht, Mohammad Ali Abdullah Almoyad, Shadma Wahab, Subhash Chandra & Veena Pande. (2023) Screening of potential inhibitors of Leishmania major N-myristoyltransferase from Azadirachta indica phytochemicals for leishmaniasis drug discovery by molecular docking, molecular dynamics simulation and density functional theory methods. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-18.
Read now
Satabdi Saha, Rakesh Srivastava, Parishmita Sarma, Tarun Kumar Bhatt, Amresh Prakash & Diwakar Kumar. (2023) Identification of potential inhibitors of Leishmania donovani Sterol 24-C- methyltransferase: in silico and in vitro studies. Molecular Simulation 49:13-14, pages 1311-1323.
Read now
Deep Bhowmik, Achyut Bhuyan, Seshan Gunalan, Gugan Kothandan & Diwakar Kumar. (2023) In silico and immunoinformatics based multiepitope subunit vaccine design for protection against visceral leishmaniasis. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-22.
Read now
Raimunda Nonata Ribeiro Sampaio. (2023) Pharmacotherapy in leishmaniasis: old, new treatments, their impacts and expert opinion. Expert Opinion on Pharmacotherapy 24:2, pages 153-158.
Read now
Mousumi Sinha, Rahul Jagadeesan, Neeraj Kumar, Satabdi Saha, Gugan Kothandan & Diwakar Kumar. (2022) In-silico studies on Myo inositol-1-phosphate synthase of Leishmania donovani in search of anti-leishmaniasis. Journal of Biomolecular Structure and Dynamics 40:8, pages 3371-3384.
Read now
Jaelson Santos Silva, Éverton Leandro França Ferreira, Amanda Maciel Lima, Ruth Raquel Soares de Farias, Bruno Quirino Araújo, José Carlos Quilles Junior, Rodolfo Ritchelle Lima Santos, Fernando Aécio de Amorim Carvalho, Mahendra Rai, Gerardo Magela Vieira Júnior & Mariana Helena Chaves. (2022) Four new cycloartane-type triterpenoids from the leaves of Combretum mellifluum Eichler: assessment of their antioxidant and antileishmanial activities. Journal of Toxicology and Environmental Health, Part A 85:9, pages 364-375.
Read now
Hulubanchi Nigatu, Alemnesh Belay, Hiwot Ayalew, Besufekad Abebe, Alemu Tadesse, Yitagesu Tewabe & Abel Degu. (2021) In vitro Antileishmanial Activity of Some Ethiopian Medicinal Plants. Journal of Experimental Pharmacology 13, pages 15-22.
Read now
Jovana Sádlová, Lucie Podešvová, Tomáš Bečvář, Claretta Bianchi, Evgeny S. Gerasimov, Andreu Saura, Kristýna Glanzová, Tereza Leštinová, Nadezhda S. Matveeva, Ľubomíra Chmelová, Denisa Mlacovská, Tatiana Spitzová, Barbora Vojtková, Petr Volf, Vyacheslav Yurchenko & Natalya Kraeva. (2021) Catalase impairs Leishmania mexicana development and virulence. Virulence 12:1, pages 852-867.
Read now
Mahboobeh Jafari, Samira Sadat Abolmaali, Ali Mohammad Tamaddon, Kamiar Zomorodian & Bahador Shahriarirad (Sarkari). (2021) Nanotechnology Approaches for Delivery and Targeting of Amphotericin B in Fungal and Parasitic Diseases. Nanomedicine 16:10, pages 857-877.
Read now
Deep Bhowmik, Rahul Jagadeesan, Praveen Rai, Rajat Nandi, Kothandan Gugan & Diwakar Kumar. (2021) Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of Leishmania donovani nuclear DNA primase using ligand based virtual screening, docking and molecular dynamics approaches. Journal of Biomolecular Structure and Dynamics 39:5, pages 1838-1852.
Read now
Jitendra Kuldeep, Karthik R.Pavneet Kaur, Neena Goyal & Mohammad Imran Siddiqi. (2021) Identification of potential anti-leishmanial agents using computational investigation and biological evaluation against trypanothione reductase. Journal of Biomolecular Structure and Dynamics 39:3, pages 960-969.
Read now
Sunita Yadav, Jay Prakash, Harish Shukla, Kanhu Charan Das, Timir Tripathi & Vikash Kumar Dubey. (2020) Design of a multi-epitope subunit vaccine for immune-protection against Leishmania parasite. Pathogens and Global Health 114:8, pages 471-481.
Read now
Nasrin Masoudzadeh, Amir Mizbani & Sima Rafati. (2020) Transcriptomic profiling in Cutaneous Leishmaniasis patients. Expert Review of Proteomics 17:7-8, pages 533-541.
Read now
Juliana Q. Reimão, Débora P. Pita Pedro & Adriano C. Coelho. (2020) The preclinical discovery and development of oral miltefosine for the treatment of visceral leishmaniasis: a case history. Expert Opinion on Drug Discovery 15:6, pages 647-658.
Read now
Beatriz Coutinho De Oliveira, Malcolm S. Duthie & Valéria Rêgo Alves Pereira. (2020) Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis. Human Vaccines & Immunotherapeutics 16:4, pages 919-930.
Read now
Haraprasad Mandal, Saravanan Vijayakumar, Shalini Yadav, Shubhankar Kumar Singh & Pradeep Das. (2019) Validation of NAD synthase inhibitors for inhibiting the cell viability of Leishmania donovani: In silico and in vitro approach. Journal of Biomolecular Structure and Dynamics 37:17, pages 4481-4493.
Read now
Mohini Soni, Gaurava Srivastava, Karthik Ramalingam, Anil Kumar Shakya, Mohammad Imran Siddiqi & J. Venkatesh Pratap. Identification of potent inhibitors for Leishmania donovani homoserine kinase: an integrated in silico and kinetic study. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-16.
Read now
Fabian Audu Ugbe, Gideon Adamu Shallangwa, Adamu Uzairu, Ibrahim Abdulkadir, Emmanuel Israel Edache, Wafa Abdullah I. Al-Megrin, Samia T. Al-Shouli, Ying Wang & Mohnad Abdalla. Cheminformatics-based discovery of new organoselenium compounds with potential for the treatment of cutaneous and visceral leishmaniasis. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-24.
Read now
Elnaz Taghizadeh, Ali Khamesipour, Bahareh Basirpour & Seyed Abdollah Hosseini. Evaluation of the in vitro Antileishmanial Activity of Chitosan-Coated Nanoemulsions of Ozonated Olive Oil. Ozone: Science & Engineering 0:0, pages 1-10.
Read now

Articles from other publishers (210)

Fabian Audu Ugbe, Emmanuel Israel Edache, Shola Elijah Adeniji, David Ebuka Arthur, Abduljelil Ajala, Samuel Ndaghiya Adawara, Stephen Ejeh & Zakari Ya'U Ibrahim. (2024) Computational evaluation of the inhibitory potential of some urea, thiourea, and selenourea derivatives of diselenides against leishmaniasis: 2D-QSAR, pharmacokinetics, molecular docking, and molecular dynamics simulation. Journal of Molecular Structure 1302, pages 137473.
Crossref
Abrar Ul Haq, Idrees M. Allaie, Shahana R. Tramboo & Tanmoy Rana. 2024. Principles and Practices of Canine and Feline Clinical Parasitic Diseases. Principles and Practices of Canine and Feline Clinical Parasitic Diseases 243 251 .
Shweta Khandibharad & Shailza Singh. (2024) Synthetic biology for combating leishmaniasis. Frontiers in Microbiology 15.
Crossref
Lívia Maria Coelho de Carvalho Moreira, Ana Beatriz Almeida de Sousa Silva, Kaline de Araújo Medeiros, João Augusto Oshiro Júnior, Dayanne Tomaz Casimiro da Silva & Bolívar Ponciano Goulart de Lima Damasceno. (2024) Effectiveness In Vivo and In Vitro of Polymeric Nanoparticles as a Drug Release System in the Treatment of Leishmaniasis. Current Medicinal Chemistry 31:3, pages 286-307.
Crossref
Jia Tao & Wei Jia. 2024. Molecular Medical Microbiology. Molecular Medical Microbiology 3061 3068 .
Shashi Saini, Anshul Anand, Abhishek Singh, Baishakhi Mahapatra, Shruti Sirohi, Samer Singh & Rakesh K. Singh. (2023) Swarna Bhasma Induces Antigen-Presenting Abilities of Macrophages and Helps Antigen Experienced CD4+ T Cells to Acquire Th1 Phenotypes Against Leishmania donovani Antigens. Biological Trace Element Research 202:1, pages 210-220.
Crossref
Luana Ribeiro dos Anjos, Vanessa Maria Rodrigues de Souza, Yasmim Alves Aires Machado, Vitor Moreira Partite, Mohammed Aufy, Geovane Dias Lopes, Christian Studenik, Carlos Roberto Alves, Gert Lubec, Eduardo Rene Perez Gonzalez & Klinger Antonio da Franca Rodrigues. (2023) Evidence of Guanidines Potential against Leishmania (Viannia) braziliensis: Exploring In Vitro Effectiveness, Toxicities and of Innate Immunity Response Effects. Biomolecules 14:1, pages 26.
Crossref
Pawan Kumar, Prakash Kumar, Ashish Shrivastava, Mukhtar Ahmad Dar, Kiran Bharat Lokhande, Nidhi Singh, Ashutosh Singh, Ravichandiran Velayutham & Debabrata Mandal. (2023) Immunoinformatics-based multi-epitope containing fused polypeptide vaccine design against visceral leishmaniasis with high immunogenicity and TLR binding. International Journal of Biological Macromolecules 253, pages 127567.
Crossref
Jéssica Adriana Jesus, Thays Nicolli Fragoso da Silva, Ilza Maria Oliveira Sousa, Aurea Favero Ferreira, Márcia Dalastra Laurenti, Paulo Cardoso da Costa, Domingos de Carvalho Ferreira & Luiz Felipe Domingues Passero. (2023) Nanostructured Lipid Carriers as Robust Systems for Lupeol Delivery in the Treatment of Experimental Visceral Leishmaniasis. Pharmaceuticals 16:12, pages 1646.
Crossref
Hannah N. Corman, Case W. McNamara & Malina A. Bakowski. (2023) Drug Discovery for Cutaneous Leishmaniasis: A Review of Developments in the Past 15 Years. Microorganisms 11:12, pages 2845.
Crossref
Cássio Meira, Jaqueline Silva, Helenita Quadros, Laís Silva, Breno Barreto, Vinícius Rocha, Larissa Bomfim, Emanuelle Santos & Milena Soares. (2023) Galectins in Protozoan Parasitic Diseases: Potential Applications in Diagnostics and Therapeutics. Cells 12:23, pages 2671.
Crossref
Rajan Singh, Anshul Anand, Baishakhi Mahapatra, Shashi Saini, Abhishek Singh, Samer Singh, Vinod Kumar, Pradeep Das, Sangram Singh & Rakesh K. Singh. (2023) Adjuvantation of whole-killed Leishmania vaccine with anti-CD200 and anti-CD300a antibodies potentiates its efficacy and provides protection against wild-type parasites. Molecular Immunology 163, pages 136-146.
Crossref
Maryna Saayman, Christina Kannigadu, Janine Aucamp, Helena D. Janse van Rensburg, Cassiem Joseph, Andrew J. Swarts & David D. N'Da. (2023) Design, synthesis, electrochemistry and anti-trypanosomatid hit/lead identification of nitrofuranylazines. RSC Medicinal Chemistry 14:10, pages 2012-2029.
Crossref
Seyedeh Roya Alizadeh, Hossein Nemati Seyghalan, Zahra Hashemi & Mohammad Ali Ebrahimzadeh. (2023) Scrophularia striata extract mediated synthesis of gold nanoparticles; their antibacterial, antileishmanial, antioxidant, and photocatalytic activities. Inorganic Chemistry Communications 156, pages 111138.
Crossref
Ali Derakhshani, Iraj Sharifi, Ehsan Salarkia, Alireza Keyhani, Setareh Agha Kuchak Afshari, Behzad Iranmanesh, Mahdieh Lashkarizadeh, Hamid Nejad Biglari, Moslem Lari Najafi & Mehdi Bamorovat. (2023) Antileishmanial potentials of azacitidine and along with meglumine antimoniate on Leishmania major: In silico prediction and in vitro analysis. PLOS ONE 18:9, pages e0291321.
Crossref
Andreina Henriquez-Figuereo, Mercedes Alcon, Esther Moreno, Carmen Sanmartín, Socorro Espuelas, Héctor de Lucio, Antonio Jiménez-Ruiz & Daniel Plano. (2023) Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity. Bioorganic Chemistry 138, pages 106624.
Crossref
Kaio Maciel de Santiago-Silva, Gabriel Felix da Silva Gomes, Carla Cristina Perez, Camilo Henrique da Silva Lima & Marcelle de Lima Ferreira Bispo. (2023) Molecular Targets for Chalcones in Antileishmanial Drug Discovery. Mini-Reviews in Medicinal Chemistry 23:14, pages 1414-1434.
Crossref
Sweta Sharma, Prasanna Anjaneyulu Yakkala, Mirza A. Beg, Supriya Tanwar, Insha Latief, Arif Khan, Kalicharan Sharma, Sayeed ur Rehman, Angamuthu Selvapandiyan & Syed Shafi. (2023) 5‐Arylidene‐2,4‐thiazolidinediones as Cysteine Protease Inhibitors against Leishmania Donovani . ChemistrySelect 8:29.
Crossref
Marianna de Carvalho Clímaco, Luiza Almeida de Figueiredo, Rayane Cristina Lucas, Guilherme Rafael Gomide Pinheiro, Luísa Mourão Dias Magalhães, Ana Laura Grossi de Oliveira, Raquel Martins Almeida, Fernando Sérgio Barbosa, Daniella Castanheira Bartholomeu, Lilian Lacerda Bueno, Tiago Antonio Mendes, Bin Zhan, Kathryn Marie Jones, Peter Hotez, Maria Elena Bottazzi, Fabrício Marcus Silva Oliveira & Ricardo Toshio Fujiwara. (2023) Development of chimeric protein as a multivalent vaccine for human Kinetoplastid infections: Chagas disease and leishmaniasis. Vaccine 41:37, pages 5400-5411.
Crossref
Marina Petsana, Ahmed F. Roumia, Pantelis G. Bagos, Haralabia Boleti & Georgia G. Braliou. (2023) In Silico Identification and Analysis of Proteins Containing the Phox Homology Phosphoinositide-Binding Domain in Kinetoplastea Protists: Evolutionary Conservation and Uniqueness of Phox-Homology-Domain-Containing Protein Architectures. International Journal of Molecular Sciences 24:14, pages 11521.
Crossref
Ganesh Yadagiri, Aakriti Singh, Kanika Arora & Shyam Lal Mudavath. (2023) Immunotherapy and immunochemotherapy in combating visceral leishmaniasis. Frontiers in Medicine 10.
Crossref
Sarah Kymberly Santos de Lima, Jéssica Adriana Jesus, Cristiano Raminelli, Márcia Dalastra Laurenti & Luiz Felipe Domingues Passero. (2023) High Selectivity of 8-Hydroxyquinoline on Leishmania (Leishmania) and Leishmania (Viannia) Species Correlates with a Potent Therapeutic Activity In Vivo. Pharmaceuticals 16:5, pages 707.
Crossref
Mayte Aseret Martinez Niño, Juan R Camacho Galván, Urania del Rocio Castillo Cruz & Gabriela Perez-Coronado. (2023) Cutaneous Leishmaniasis in a Non-endemic Area in Mexico. Cureus.
Crossref
Shu-Rui Li, Yi-Min Tan, Ling Zhang & Cheng-He Zhou. (2023) Comprehensive Insights into Medicinal Research on Imidazole-Based Supramolecular Complexes. Pharmaceutics 15:5, pages 1348.
Crossref
Carlos Gaona-López, Lenci K. Vazquez-Jimenez, Alonzo Gonzalez-Gonzalez, Timoteo Delgado-Maldonado, Eyrá Ortiz-Pérez, Benjamín Nogueda-Torres, Adriana Moreno-Rodríguez, Karina Vázquez, Emma Saavedra & Gildardo Rivera. (2023) Advances in Protozoan Epigenetic Targets and Their Inhibitors for the Development of New Potential Drugs. Pharmaceuticals 16:4, pages 543.
Crossref
Edlainne Pinheiro Ferreira-Sena, Daiana de Jesus Hardoim, Flavia de Oliveira Cardoso, Luiz Ney d’Escoffier, Isabela Ferreira Soares, João Pedro Rangel da Silva Carvalho, Ricardo Almir Angnes, Stenio Perdigão Fragoso, Carlos Roberto Alves, Salvatore Giovanni De-Simone, Josué da Costa Lima-Junior, Alvaro Luiz Bertho, Tânia Zaverucha-do-Valle, Franklin da Silva & Kátia da Silva Calabrese. (2023) A New Strategy for Mapping Epitopes of LACK and PEPCK Proteins of Leishmania amazonensis Specific for Major Histocompatibility Complex Class I. International Journal of Molecular Sciences 24:6, pages 5972.
Crossref
Joao Henrique Ghilardi Lago & Luiz Felipe Domingues Passero. (2023) Recent Advances and Future Challenges in Drug Discovery for Leishmaniasis Based on Natural Products. Current Organic Chemistry 27:5, pages 379-383.
Crossref
Anshul Anand, Rajan Singh, Shashi Saini, Baishakhi Mahapatra, Abhishek Singh, Samer Singh & Rakesh K. Singh. (2023) Leishmania donovani induces CD300a expression to dampen effector properties of CD11c+ dendritic and antigen activated CD8+ T cells. Acta Tropica 239, pages 106826.
Crossref
Xinlei Wang, Jie Chen & Jingtong Zheng. (2023) The roles of COX-2 in protozoan infection. Frontiers in Immunology 14.
Crossref
Chinyere A. Knight, David R. Harris, Shifaa O. Alshammari, Ayele Gugssa, Todd Young & Clarence M. Lee. (2023) Leishmaniasis: Recent epidemiological studies in the Middle East. Frontiers in Microbiology 13.
Crossref
Keerti, Narendra Kumar Yadav, Sumit Joshi, Sneha Ratnapriya, Amogh Anant Sahasrabuddhe & Anuradha Dube. (2023) Combined immunotherapeutic effect of Leishmania-derived recombinant aldolase and Ambisome against experimental visceral leishmaniasis. Journal of Microbiology, Immunology and Infection 56:1, pages 163-171.
Crossref
Julyanne Maria Saraiva de Sousa, Thaís Amanda de Lima Nunes, Raiza Raianne Luz Rodrigues, João Paulo Araújo de Sousa, Maria da Conceição Albuquerque Val, Francisco Alex da Rocha Coelho, Airton Lucas Sousa dos Santos, Nicolle Barreira Maciel, Vanessa Maria Rodrigues de Souza, Yasmim Alves Aires Machado, Paulo Sérgio de Araújo Sousa, Alyne Rodrigues de Araújo, Jefferson Almeida Rocha, Damião Pergentino de Sousa, Marcos Vinicius da Silva, Daniel Dias Rufino Arcanjo & Klinger Antônio da Franca Rodrigues. (2023) Cytotoxic and Antileishmanial Effects of the Monoterpene β-Ocimene. Pharmaceuticals 16:2, pages 183.
Crossref
Gehan A Pendlebury, Peter Oro, Kerstyn Ludlow, Drew Merideth, William Haynes & Vikas Shrivastava. (2023) Relevant Dermatoses Among U.S. Military Service Members: An Operational Review of Management Strategies and Telemedicine Utilization. Cureus.
Crossref
Alfredo Juárez-Saldivar, Nuria E. Campillo, Eyra Ortiz-Perez, Alma D. Paz-Gonzalez, Emma Saavedra & Gildardo Rivera. (2023) In Silico Analysis of Potential Drug Targets for Protozoan Infections. Medicinal Chemistry 19:1, pages 91-98.
Crossref
Kaio M. Santiago-Silva, Priscila G. Camargo & Marcelle L.F. Bispo. (2023) Promising Molecular Targets Related to Polyamine Biosynthesis in Drug Discovery against Leishmaniasis. Medicinal Chemistry 19:1, pages 2-9.
Crossref
Niurka Mollineda-Diogo, Claudia Sissely Chaviano-Montes de Oca, Sergio Sifontes-Rodríguez, Teresa Espinosa-Buitrago, Lianet Monzote-Fidalgo, Alfredo Meneses-Marcel, Aliuska Morales-Helguera, Yunierkis Perez-Castillo & Vicente Arán-Redó. (2023) Antileishmanial activity of 5-nitroindazole derivatives. Therapeutic Advances in Infectious Disease 10.
Crossref
Naveen Dhingra, Kapish Kapoor, Shaligram Sharma & Ankur Saxena. (2023) Towards further understanding the structural insights of isoxazoles analogues against leishmaniasis using QSAR, molecular docking and molecular dynamics model. Journal of the Indian Chemical Society 100:1, pages 100847.
Crossref
Patrick O. Sakyi, Emmanuel Broni, Richard K. Amewu, Whelton A. MillerIIIIII, Michael D. Wilson & Samuel K. Kwofie. (2023) Targeting Leishmania donovani sterol methyltransferase for leads using pharmacophore modeling and computational molecular mechanics studies. Informatics in Medicine Unlocked 37, pages 101162.
Crossref
Bruce M. Wenig & Juan C. Hernandez-Prera. 2023. Atlas of Head and Neck Pathology. Atlas of Head and Neck Pathology 10 86.e7 .
Surbhi Badhwar, Angamuthu Selvapandiyan & Niti Puri. 2023. Challenges and Solutions Against Visceral Leishmaniasis. Challenges and Solutions Against Visceral Leishmaniasis 43 62 .
Shaikh Shuhail, Saswata Das, Tirtharaj Datta, Priya Tyagi, Mohd Tasleem, Riya Singh, Parma Nand & Garima Chouhan. 2023. Challenges and Solutions Against Visceral Leishmaniasis. Challenges and Solutions Against Visceral Leishmaniasis 245 302 .
Ganesh Yadagiri & Shyam Lal Mudavath. 2023. Recent Advances in Pharmaceutical Innovation and Research. Recent Advances in Pharmaceutical Innovation and Research 479 498 .
Yash Gupta, Steven Goicoechea, Jesse Vance, Andres P. Trujillo, Akankcha Alok, Samuel K. Kwofie, Brijesh Rathi, Ravi Durvasula & Prakasha Kempaiah. 2023. Natural Product Based Drug Discovery Against Human Parasites. Natural Product Based Drug Discovery Against Human Parasites 329 383 .
Olayinka Osuolale. 2023. Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges. Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges 235 261 .
Rephany F. Peixoto, Bruna M. Gois, Marineuma Martins, Pedro Henrique S. Palmeira, Juliana C. Rocha, Juliana A. S. Gomes, Fátima L. A. A. Azevedo, Robson C. Veras, Isac A. de Medeiros, Teresa C. S. L. Grisi, Demétrius A. M. de Araújo, Ian P. G. Amaral & Tatjana S. L. Keesen. (2022) Characterization of Regulatory T Cells in Patients Infected by Leishmania Infantum. Tropical Medicine and Infectious Disease 8:1, pages 18.
Crossref
Ali A. Rabaan, Muhammed A. Bakhrebah, Ranjan K. Mohapatra, Ramadan Abdelmoez Farahat, Manish Dhawan, Sara Alwarthan, Mohammed Aljeldah, Basim R. Al Shammari, Amal H. Al-Najjar, Mona A. Alhusayyen, Ghadeer H. Al-Absi, Yahya Aldawood, Abdulmonem A. Alsaleh, Saleh A. Alshamrani, Souad A. Almuthree, Abdulsalam Alawfi, Amer Alshengeti, Ameen S. S. Alwashmi, Khalid Hajissa & Majed S. Nassar. (2022) Omics Approaches in Drug Development against Leishmaniasis: Current Scenario and Future Prospects. Pathogens 12:1, pages 39.
Crossref
Subir Karmakar, Greta Volpedo, Wen-Wei Zhang, Patrick Lypaczewski, Nevien Ismail, Fabiano Oliveira, James Oristian, Claudio Meneses, Sreenivas Gannavaram, Shaden Kamhawi, Shinjiro Hamano, Jesus G. Valenzuela, Greg Matlashewski, Abhay R. Satoskar, Ranadhir Dey & Hira L. Nakhasi. (2022) Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis. npj Vaccines 7:1.
Crossref
Fabian Audu Ugbe, Gideon Adamu Shallangwa, Adamu Uzairu & Ibrahim Abdulkadir. (2022) A combined 2-D and 3-D QSAR modeling, molecular docking study, design, and pharmacokinetic profiling of some arylimidamide-azole hybrids as superior L. donovani inhibitors. Bulletin of the National Research Centre 46:1.
Crossref
Fabian Audu Ugbe, Gideon Adamu Shallangwa, Adamu Uzairu & Ibrahim Abdulkadir. (2022) Theoretical activity prediction, structure-based design, molecular docking and pharmacokinetic studies of some maleimides against Leishmania donovani for the treatment of leishmaniasis. Bulletin of the National Research Centre 46:1.
Crossref
Mei Feng, Yiru Jin, Sihyung Yang, Arline M. Joachim, Yu Ning, Luis M. Mori-Quiroz, Jacob Fromm, Chamani Perera, Kai Zhang, Karl A. Werbovetz & Michael Zhuo Wang. (2022) Sterol profiling of Leishmania parasites using a new HPLC-tandem mass spectrometry-based method and antifungal azoles as chemical probes reveals a key intermediate sterol that supports a branched ergosterol biosynthetic pathway. International Journal for Parasitology: Drugs and Drug Resistance 20, pages 27-42.
Crossref
Jesús García-Díaz, Julio César Escalona-Arranz, Ania Ochoa-Pacheco, Sócrates Golzio Dos Santos, Rosalia González-Fernández, Julio Alberto Rojas-Vargas, Lianet Monzote & William N. Setzer. (2022) Chemical Composition and In Vitro and In Silico Antileishmanial Evaluation of the Essential Oil from Croton linearis Jacq. Stems. Antibiotics 11:12, pages 1712.
Crossref
Abdalla A. Hassan, Hassan E. Khalid, Abdelwahab H. Abdalla, Maowia M. Mukhtar, Wadah J. Osman & Thomas Efferth. (2022) Antileishmanial Activities of Medicinal Herbs and Phytochemicals In Vitro and In Vivo: An Update for the Years 2015 to 2021. Molecules 27:21, pages 7579.
Crossref
Farhad Ali Khattak, Taj Ali Khan, Mubashir Hussain, Shahid Niaz Khan, Naeem Ullah, Basheer Rehman, Muhammad Qasim, Aziz Ur Rehman Safi, Muhammad Ishfaq & Saima Afaq. (2022) Analysis of associated risk factors among recurrent cutaneous leishmaniasis patients: A cross-sectional study in Khyber Pakhtunkhwa, Pakistan. Journal of Infection and Public Health 15:11, pages 1175-1179.
Crossref
Diksha Kumari, Shavi Mahajan, Parampreet Kour & Kuljit Singh. (2022) Virulence factors of Leishmania parasite: Their paramount importance in unraveling novel vaccine candidates and therapeutic targets. Life Sciences 306, pages 120829.
Crossref
Michele Verboni, Diego Olivieri & Simone Lucarini. (2022) A recent update on new synthetic chiral compounds with antileishmanial activity. Chirality 34:10, pages 1279-1297.
Crossref
Aakriti Singh, Ganesh Yadagiri, Aaqib Javaid, Krishna Kumar Sharma, Anurag Verma, Om Prakash Singh, Shyam Sundar & Shyam Lal Mudavath. (2022) Hijacking the intrinsic vitamin B 12 pathway for the oral delivery of nanoparticles, resulting in enhanced in vivo anti-leishmanial activity . Biomaterials Science 10:19, pages 5669-5688.
Crossref
Yosser Zina Abdelkrim, Emna Harigua-Souiai, Imen Bassoumi-Jamoussi, Mourad Barhoumi, Josette Banroques, Khadija Essafi-Benkhadir, Michael Nilges, Arnaud Blondel, N. Kyle Tanner & Ikram Guizani. (2022) Enzymatic and Molecular Characterization of Anti-Leishmania Molecules That Differently Target Leishmania and Mammalian eIF4A Proteins, LieIF4A and eIF4AMus. Molecules 27:18, pages 5890.
Crossref
María Cabello-Donayre, Lina M. Orrego, Elisa Herráez, Raquel García-Hernández & José M. Pérez-Victoria. (2022) New Insights on Heme Uptake in Leishmania spp.. International Journal of Molecular Sciences 23:18, pages 10501.
Crossref
Nergiz GÜRBÜZ ÇOLAK, Emel Öykü ÇETİN UYANIKGİL, Yusuf ÖZBEL & Seray TÖZ. (2022) The Designing of a Gel Formulation with Chitosan Polymer Using Liposomes as Nanocarriers of Amphotericin B for a Non-invasive Treatment Model of Cutaneous Leishmaniasis. Acta Parasitologica 67:3, pages 1354-1363.
Crossref
Mohini Soni & J. Venkatesh Pratap. (2022) Development of Novel Anti-Leishmanials: The Case for Structure-Based Approaches. Pathogens 11:8, pages 950.
Crossref
Xinlei Wang, Jie Chen & Jingtong Zheng. (2022) The state of the art of extracellular vesicle research in protozoan infection. Frontiers in Genetics 13.
Crossref
Christina Kannigadu, Janine Aucamp & David D. N'Da. (2022) Exploring novel nitrofuranyl sulfonohydrazides as anti‐ Leishmania and anti‐cancer agents: Synthesis, in vitro efficacy and hit identification . Chemical Biology & Drug Design 100:2, pages 267-279.
Crossref
Bahareh Vakili, Navid Nezafat, Manica Negahdaripour & Younes Ghasemi. (2022) A structural vaccinology approach for in silico designing of a potential self-assembled nanovaccine against Leishmania infantum. Experimental Parasitology 239, pages 108295.
Crossref
Renata Rocha da Silva, Fernanda de Santana Fontes Vasconcelos, Débora dos Santos Tavares & Priscila Lima dos Santos. (2022) Association between interleukin 10 (IL-10) polymorphisms and leishmaniasis progression: a systematic review and meta-analysis. Scientific Reports 12:1.
Crossref
Luciana M. Ribeiro Antinarelli, Nícolas Glanzmann, Débora V. C. Mendonça, Daniela P. Lage, João A. Oliveira-da-Silva, Grasiele S. V. Tavares, Ana Maria R. S. Carvalho, Camila S. Freitas, Vívian T. Martins, Mariana C. Duarte, Daniel Menezes-Souza, Adilson David da Silva, Eduardo Antônio Ferraz Coelho & Elaine Soares Coimbra. (2022) Parasitological and immunological evaluation of a quinoline derivative salt incorporated into a polymeric micelle formulation against Leishmania infantum infection. Parasitology Research 121:7, pages 2129-2140.
Crossref
Patrícia de A. Machado, Pollyanna S. Gomes, Monique P. D. Carneiro, Victor Midlej, Elaine S. Coimbra & Herbert L. de Matos Guedes. (2022) Effects of a Serine Protease Inhibitor N-p-Tosyl-L-phenylalanine Chloromethyl Ketone (TPCK) on Leishmania amazonensis and Leishmania infantum. Pharmaceutics 14:7, pages 1373.
Crossref
Patrick O. Sakyi, Emmanuel Broni, Richard K. Amewu, Whelton A. MillerIIIIII, Michael D. Wilson & Samuel Kojo Kwofie. (2022) Homology Modeling, de Novo Design of Ligands, and Molecular Docking Identify Potential Inhibitors of Leishmania donovani 24-Sterol Methyltransferase. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Mehvish Khokhar, Muhammad Adnan Shereen, Momin Khan, Rahat Ullah Khan, Aamir Sohail, Imdad Ullah Khan, Inam Ullah Khan & Saadullah Khattak. (2021) In vitro efficacy of polymer coated miltefosine drug against leishmania tropica. Journal of Parasitic Diseases 46:2, pages 366-376.
Crossref
Sooyoung Shin, Soonbum Kwon & Yoon Yeo. (2022) Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections. Pharmaceutical Research 39:6, pages 1085-1114.
Crossref
Nasma I. Al-Mamary & Haitham L. Al-Hayali. (2022) Effect of Synergism of Thalidomide and Liposomal Amphotericin-B on Leishmania tropica and Leishmania donovani Promastigote. Bionatura 7:2, pages 1-9.
Crossref
R. Silva-Carvalho, T. Leão, A. I. Bourbon, C. Gonçalves, L. M. Pastrana, P. Parpot, I. Amorim, A. M. Tomás & F. M. Gama. (2022) Hyaluronic acid–amphotericin B nanocomplexes: a promising anti-leishmanial drug delivery system. Biomaterials Science 10:8, pages 1952-1967.
Crossref
Cauê Benito Scarim, Renan Lira de Farias, Diego Eidy Chiba & Chung Man Chin. (2022) Insight into Recent Drug Discoveries against Trypanosomatids and Plasmodium spp Parasites: New Metal-based Compounds. Current Medicinal Chemistry 29:13, pages 2334-2381.
Crossref
Sophia Häfner. (2022) Polymeric promotion. Microbes and Infection 24:3, pages 104910.
Crossref
Maria Simone Pereira Maciel, Aramys Silva dos Reis & Queli Cristina Fidelis. (2022) Antileishmanial potential of species from the family Lamiaceae: chemical and biological aspects of non-volatile compounds. Acta Tropica 228, pages 106309.
Crossref
Angélica Patricia Isaac-Márquez & Claudio Manuel Lezama-Dávila. (2022) In vitro leishmanicidal activity of two cholesterol derivatives. World Journal of Microbiology and Biotechnology 38:4.
Crossref
Süha Kenan Arserim, Ahmet Mermer & Yusuf Özbel. (2022) Fauna, Seasonal Activity, and Altitudinal Distribution of Phlebotomine Sand Flies (Diptera: Psychodidae) in Leishmaniasis Endemic Area, Aydın Mountains, and Surroundings in Western Turkey. Turkish Journal of Parasitology 46:1, pages 60-71.
Crossref
KEYA MALLICK & SUGATO BANERJEE. (2022) ROLE OF ANTIDEPRESSANTS AGAINST LEISHMANIASIS. International Journal of Pharmacy and Pharmaceutical Sciences, pages 1-7.
Crossref
Sepideh Haghdoust, Mina Noroozbeygi, Mostafa Hajimollahoseini, Mandana Mohseni Masooleh & Farshid Yeganeh. (2022) A candidate vaccine composed of live nonpathogenic Iranian Lizard Leishmania mixed with Chitin microparticles protects mice against Leishmania major infection. Acta Tropica 227, pages 106298.
Crossref
Behnaz Jeddi, Sedigheh Saberi, J. Carlos Menéndez & Saghi Sepehri. (2021) Synthesis and Biological Evaluation of Tetrahydropyrimidine and Dihydropyridine Derivatives Against Leishmania Major. Acta Parasitologica 67:1, pages 255-266.
Crossref
Manoj Kumar Singh, Arpita Das, Rudra P Saha, Joydeep Paul & Debkumar Nandi. (2022) Leishmaniasis: Plants as a source of antileishmanial agents. Journal of Experimental Biology and Agricultural Sciences 10:1, pages 227-247.
Crossref
Maureen A. Carey, Gregory L. Medlock, Michał Stolarczyk, William A. Petri, Jennifer L. Guler & Jason A. Papin. (2022) Comparative analyses of parasites with a comprehensive database of genome-scale metabolic models. PLOS Computational Biology 18:2, pages e1009870.
Crossref
Marta H. Branquinha, Pedro S. S. Araújo, Simone S. C. Oliveira, Leandro S. Sangenito, Diego S. Gonçalves, Sérgio H. Seabra, Claudia M. d’Avila-Levy & André L. S. Santos. (2022) Antileishmanial Efficacy of the Calpain Inhibitor MDL28170 in Combination with Amphotericin B. Tropical Medicine and Infectious Disease 7:2, pages 29.
Crossref
Hossein Montakhab-Yeganeh, Reza Shafiei, Mehdi Najm, Leila Masoori, Ashok Aspatwar & Alireza Badirzadeh. (2022) Immunogenic properties of empty pcDNA3 plasmid against zoonotic cutaneous leishmaniasis in mice. PLOS ONE 17:2, pages e0263993.
Crossref
Bernard Ong’ondo Osero, Zama Cele, Raphael Taiwo Aruleba, Rebeng A. Maine, Mumin Ozturk, Manfred B. Lutz, Frank Brombacher & Ramona Hurdayal. (2022) Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against Leishmania mexicana Infection. Frontiers in Immunology 12.
Crossref
Wetpisit Chanmol, Padet Siriyasatien & Nuchpicha Intakhan. (2022) In vitro anti- Leishmania activity of 8-hydroxyquinoline and its synergistic effect with amphotericin B deoxycholate against Leishmania martiniquensis . PeerJ 10, pages e12813.
Crossref
Apeksha Anand, Deep Chandra Balodi, Karthik Ramalingam, Shailendra Yadav & Neena Goyal. (2022) Immunological characterization of rLdTCP1γ for its prophylactic potential against visceral leishmaniasis in hamster model. Molecular Immunology 141, pages 33-42.
Crossref
Amanda Cristina Machado Carloto, Bruna Taciane da Silva Bortoleti, Ana Carolina Jacob Rodrigues, Taylon Felipe Silva, Fernanda Tomiotto-Pellissier, Danielle Lazarin Bidóia, Manoela Daiele Gonçalves, João Paulo Assolini, Robert F.H. Dekker, Aneli M. Barbosa-Dekker, Idessania Nazareth Costa, Ivete Conchon-Costa, Milena Menegazzo Miranda-Sapla & Wander Rogério Pavanelli. (2022) Botryosphaeran, [(1 → 3)(1 → 6)-β-D-glucan], induces apoptosis-like death in promastigotes of Leishmania amazonensis, and exerts a leishmanicidal effect on infected macrophages by activating NF-kB and producing pro-inflammatory molecules. Chemico-Biological Interactions 351, pages 109713.
Crossref
Ritika Kabra & Shailza Singh. 2022. Protein Design and Structure. Protein Design and Structure 399 418 .
Rashika El Ridi. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity 510 529 .
Alireza Lari, Niloofar Lari & Atefeh Biabangard. (2021) Immunoinformatics Approach to Design a Novel Subunit Vaccine Against Visceral Leishmaniasis. International Journal of Peptide Research and Therapeutics 28:1.
Crossref
Esther von Stebut. 2022. Braun-Falco´s Dermatology. Braun-Falco´s Dermatology 375 390 .
Esther von Stebut. 2020. Braun-Falco´s Dermatology. Braun-Falco´s Dermatology 1 16 .
Seyed Naser Emadi, Bahareh Abtahi-Naeini & Almudena Nuño González. 2022. Atlas of Dermatology, Dermatopathology and Venereology. Atlas of Dermatology, Dermatopathology and Venereology 159 189 .
Irene Betancourt-Conde, Claudia Avitia-Domínguez, Alicia Hernández-Campos, Rafael Castillo, Lilián Yépez-Mulia, Jesús Oria-Hernández, Sara T. Méndez, Erick Sierra-Campos, Mónica Valdez-Solana, Siseth Martínez-Caballero, Juan A. Hermoso, Antonio Romo-Mancillas & Alfredo Téllez-Valencia. (2021) Benzimidazole Derivatives as New and Selective Inhibitors of Arginase from Leishmania mexicana with Biological Activity against Promastigotes and Amastigotes. International Journal of Molecular Sciences 22:24, pages 13613.
Crossref
Anita Cohen & Nadine Azas. (2021) Challenges and Tools for In Vitro Leishmania Exploratory Screening in the Drug Development Process: An Updated Review. Pathogens 10:12, pages 1608.
Crossref
Orawan Phuphisut, Chanyapat Nitatsukprasert, Nattaphol Pathawong, Boonsong Jaichapor, Arissara Pongsiri, Poom Adisakwattana & Alongkot Ponlawat. (2021) Sand fly identification and screening for Leishmania spp. in six provinces of Thailand. Parasites & Vectors 14:1.
Crossref
Mohammad Varzandeh, Reza Mohammadinejad, Keyvan Esmaeilzadeh-Salestani, Ali Dehshahri, Ali Zarrabi & Abbas Aghaei-Afshar. (2021) Photodynamic therapy for leishmaniasis: Recent advances and future trends. Photodiagnosis and Photodynamic Therapy 36, pages 102609.
Crossref
Patrick O. Sakyi, Richard K. Amewu, Robert N. O. A. Devine, Alfred K. Bienibuor, Whelton A. MillerIIIIII & Samuel K. Kwofie. (2021) Unravelling the myth surrounding sterol biosynthesis as plausible target for drug design against leishmaniasis. Journal of Parasitic Diseases 45:4, pages 1152-1171.
Crossref
Shams Tabrez, Fazlur Rahman, Rahat Ali, Fida Muhammad, Bader Mohammed Alshehri, Mohammed A. Alaidarous, Saeed Banawas, Abdul Aziz Bin Dukhyil & Abdur Rub. (2021) Repurposing of FDA ‐approved drugs as inhibitors of sterol C‐24 methyltransferase of Leishmania donovani to fight against leishmaniasis . Drug Development Research 82:8, pages 1154-1161.
Crossref
Faustina Pappoe & Samuel Victor Nuvor. 2021. Antimicrobial Immune Response. Antimicrobial Immune Response.
Luiz H. C. Assis, Débora Andrade-Silva, Mark E. Shiburah, Beatriz C. D. de Oliveira, Stephany C. Paiva, Bryan E. Abuchery, Yete G. Ferri, Veronica S. Fontes, Leilane S. de Oliveira, Marcelo S. da Silva & Maria Isabel N. Cano. (2021) Cell Cycle, Telomeres, and Telomerase in Leishmania spp.: What Do We Know So Far?. Cells 10:11, pages 3195.
Crossref
Qi Shi, Minjun Huang, Xiaoli Li, Xiaoyan Zheng, Fei Wang, Yang Zou, Lei Wang & Jidong Jia. (2021) Clinical and laboratory characteristics of hemophagocytic lymphohistiocytosis induced by Leishmania infantum infection. PLOS Neglected Tropical Diseases 15:11, pages e0009944.
Crossref
Richa Arya, Chetna Dhembla, Ravindra D. Makde, Monica Sundd & Suman Kundu. (2021) An overview of the fatty acid biosynthesis in the protozoan parasite Leishmania and its relevance as a drug target against leishmaniasis. Molecular and Biochemical Parasitology 246, pages 111416.
Crossref
Ojasvi Gupta, Tathagata Pradhan, Rohit Bhatia & Vikramdeep Monga. (2021) Recent advancements in anti-leishmanial research: Synthetic strategies and structural activity relationships. European Journal of Medicinal Chemistry 223, pages 113606.
Crossref
Margarida DuarteCleide FerreiraGurleen Kaur Khandpur, Tamara Flohr, Jannik ZimmermannHelena CastroJohannes M. Herrmann, Bruce MorganAna M. Tomás. (2021) Leishmania type II dehydrogenase is essential for parasite viability irrespective of the presence of an active complex I . Proceedings of the National Academy of Sciences 118:42.
Crossref
Silvia Stefania Longoni, Natalia Tiberti, Zeno Bisoffi & Chiara Piubelli. (2021) Monoclonal Antibodies for Protozoan Infections: A Future Reality or a Utopic Idea?. Frontiers in Medicine 8.
Crossref
Mario Daniel Caba-Flores, Delia Hernández-Romero, Aracely López-Monteon, Esmeralda Sánchez-Pavón, Diana Carolina Valdez-Ortega, Jaime López-Domínguez, Víctor Adolfo Romero-Cruz, Alberto Yair Limón-Flores, Ángel Trigos & Angel Ramos-Ligonio. (2021) Activity In Vitro of 2-Chloro-N-[4-(4-Chlorophenyl)-2-Thiazolyl]Acetamide Against Promastigotes of Leishmania mexicana: An Apoptosis Inducer. Acta Parasitologica 66:3, pages 1068-1073.
Crossref
Amir Atapour, Farideh Ghalamfarsa, Samaneh Naderi & Gholamreza Hatam. (2021) Designing of a Novel Fusion Protein Vaccine Candidate Against Human Visceral Leishmaniasis (VL) Using Immunoinformatics and Structural Approaches. International Journal of Peptide Research and Therapeutics 27:3, pages 1885-1898.
Crossref
Bárbara Domínguez-Asenjo, Camino Gutiérrez-Corbo, María Álvarez-Bardón, Yolanda Pérez-Pertejo, Rafael Balaña-Fouce & Rosa M. Reguera. (2021) Ex Vivo Phenotypic Screening of Two Small Repurposing Drug Collections Identifies Nifuratel as a Potential New Treatment against Visceral and Cutaneous Leishmaniasis. ACS Infectious Diseases 7:8, pages 2390-2401.
Crossref
Parvin Zamani, Seyedeh Hoda Alavizadeh, Fatemeh Fakhraee, Ali Badiee, Seyed Amir Jalali, Omid Chavoshian, Ali Khamesipour, Masoumeh Tavassoti Kheiri, Fereidoun Mahboudi & Mahmoud Reza Jaafari. (2021) Multi-antigen vaccination with LPD nanoparticles containing rgp63 and rLmaC1N proteins induced effective immune response against leishmaniasis in animal model. Journal of Drug Delivery Science and Technology 64, pages 102633.
Crossref
Vanessa Gonçalves Medeiros, Fernando Javier Durán & Karen Luise Lang. (2021) Copalic Acid: Occurrence, Chemistry, and Biological Activities. Revista Brasileira de Farmacognosia 31:4, pages 375-386.
Crossref
Rohan J. Meshram, Kamini T. Bagul, Snehal U. Aouti, Akshay M. Shirsath, Harleen Duggal & Rajesh N. Gacche. (2020) Modeling and simulation study to identify threonine synthase as possible drug target in Leishmania major. Molecular Diversity 25:3, pages 1679-1700.
Crossref
Simone SC Oliveira, Carine S Ferreira, Marta H Branquinha, André LS Santos, Marco V Chaud, Sona Jain, Juliana C Cardoso, Anđelka B Kovačević, Eliana B Souto & Patrícia Severino. (2020) Overcoming multi‐resistant leishmania treatment by nanoencapsulation of potent antimicrobials. Journal of Chemical Technology & Biotechnology 96:8, pages 2123-2140.
Crossref
Inbar Yariv, Sriram Kannan, Yifat Harel, Esthy Levy, Hamootal Duadi, Jean-Paul Lellouche, Shulamit Michaeli & Dror Fixler. (2021) Iterative optical technique for detecting anti-leishmania nanoparticles in mouse lesions. Biomedical Optics Express 12:7, pages 4496.
Crossref
Sriram Kannan, Yifat Harel, Esthy Levy, Avishay Dolitzky, Assaf E. Sagiv, Saurav Aryal, Laila Suleman, Jean-Paul Lellouche & Shulamit Michaeli. (2021) Nano-Leish-IL: A novel iron oxide-based nanocomposite drug platform for effective treatment of cutaneous leishmaniasis. Journal of Controlled Release 335, pages 203-215.
Crossref
Andrés Oliveros-Díaz, Jesús Olivero-Verbel, Yina Pájaro-González & Fredyc Díaz-Castillo. (2021) Molecular Human Targets of Bioactive Alkaloid-Type Compounds from Tabernaemontana cymose Jacq.. Molecules 26:12, pages 3765.
Crossref
Jéssica Adriana Jesus, Ilza Maria Oliveira Sousa, Thays Nicolli Fragoso da Silva, Aurea Favero Ferreira, Márcia Dalastra Laurenti, Leila Antonangelo, Caroline Silvério Faria, Paulo Cardoso da Costa, Domingos de Carvalho Ferreira & Luiz Felipe Domingues Passero. (2021) Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis. Pharmaceutics 13:6, pages 908.
Crossref
Hatim Almutairi, Michael D. Urbaniak, Michelle D. Bates, Narissara Jariyapan, Waleed S. Al-Salem, Rod J. Dillon, Paul A. Bates & Derek Gatherer. (2021) Chromosome-Scale Assembly of the Complete Genome Sequence of Leishmania ( Mundinia ) martiniquensis , Isolate LSCM1, Strain LV760 . Microbiology Resource Announcements 10:24.
Crossref
Luiz Felipe D. Passero, Erika dos Santos Brunelli, Thamara Sauini, Thais Fernanda Amorim Pavani, Jéssica Adriana Jesus & Eliana Rodrigues. (2021) The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis. Frontiers in Pharmacology 12.
Crossref
Saeideh Nikpour, Fatemeh Tabatabaie, Iraj Sharifi, Mahshid Mostafavi, Razieh T. Oliaee, Fatemeh Sharifi, Zahra Babaei, Elham Jafari, Ehsan Salarkia & Delavar Shahbazzadeh. (2021) The Fraction of the Snake Venom, Its Leishmanicidal Effect, and the Stimulation of an Anti-Leishmania Response in Infected Macrophages. Endocrine, Metabolic & Immune Disorders - Drug Targets 21:6, pages 1115-1124.
Crossref
Rafig Gurbanov. 2021. Polysaccharides. Polysaccharides 683 699 .
Rashmi Mishra & Ishan Rohatgi. (2021) Leishmaniasis. Indian Journal of Critical Care Medicine 25:S2, pages S166-S170.
Crossref
Ronna Delgado-Altamirano, Martha E. García-Aguilera, José Delgado-Domínguez, Ingeborg Becker, Eduardo Rodríguez de San Miguel, Alejandra Rojas-Molina & Nuria Esturau-Escofet. (2021) 1H NMR profiling and chemometric analysis as an approach to predict the leishmanicidal activity of dichloromethane extracts from Lantana camara (L.). Journal of Pharmaceutical and Biomedical Analysis 199, pages 114060.
Crossref
Elvira Cynthia Alves Horácio, Jéssica Hickson, Silvane Maria Fonseca Murta, Jeronimo Conceição Ruiz & Laila Alves Nahum. (2021) Perspectives From Systems Biology to Improve Knowledge of Leishmania Drug Resistance. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crhisllane Rafaele dos Santos Vasconcelos & Antonio Mauro Rezende. (2021) Systematic in silico Evaluation of Leishmania spp. Proteomes for Drug Discovery. Frontiers in Chemistry 9.
Crossref
Aline N. Silva da Gama & Maria N.C. Soeiro. (2021) Quinoline-based Compounds as Key Candidates to Tackle Drug Discovery Programs of Microbicidal Agents. Current Pharmaceutical Design 27:15, pages 1757-1762.
Crossref
Sina Bahraminegad, Abbas Pardakhty, Iraj Sharifi & Mehdi Ranjbar. (2021) The assessment of apoptosis, toxicity effects and anti-leishmanial study of Chitosan/CdO core-shell nanoparticles, eco-friendly synthesis and evaluation. Arabian Journal of Chemistry 14:4, pages 103085.
Crossref
Amalia Papadaki, Olympia Tziouvara, Anastasia Kotopouli, Petrina Koumarianou, Anargyros Doukas, Pablo Rios, Isabelle Tardieux, Maja Köhn & Haralabia Boleti. (2021) The Leishmania donovani LDBPK_220120.1 Gene Encodes for an Atypical Dual Specificity Lipid-Like Phosphatase Expressed in Promastigotes and Amastigotes; Substrate Specificity, Intracellular Localizations, and Putative Role(s). Frontiers in Cellular and Infection Microbiology 11.
Crossref
Brindha J, Balamurali M. M & Kaushik Chanda. (2021) An Overview on the Therapeutics of Neglected Infectious Diseases—Leishmaniasis and Chagas Diseases. Frontiers in Chemistry 9.
Crossref
Aline Maria Vasconcelos Queiroz, Johny Wysllas de Freitas Oliveira, Cláudia Jassica Moreno, Diego M. A. Guérin & Marcelo Sousa Silva. (2021) VLP-Based Vaccines as a Suitable Technology to Target Trypanosomatid Diseases. Vaccines 9:3, pages 220.
Crossref
Sunita Yadav, Jay Prakash, Om Prakash Singh, Mallikarjuna Rao Gedda, Shashi Bhushan Chauhan, Shyam Sundar & Vikash Kumar Dubey. (2021) IFN-γ+ CD4+T cell-driven prophylactic potential of recombinant LDBPK_252400 hypothetical protein of Leishmania donovani against visceral leishmaniasis. Cellular Immunology 361, pages 104272.
Crossref
Seyedeh Noushin Zahedi, Seyed Hossein Hejazi, Maryam Boshtam, Farahnaz Amini, Hossein Fazeli, Mahdieh Sarmadi, Mahsa Rahimi & Hossein Khanahmad. (2020) Recombinant C-Reactive Protein: A Potential Candidate for the Treatment of Cutaneous Leishmaniasis of BALB/c Mice Caused by Leishmania major. Acta Parasitologica 66:1, pages 53-59.
Crossref
Leonel Vargas-Jaimes, María Carmen Rodriguez, Rocío Argotte-Ramos, Víctor Rivelino Juárez-González, Nina Pastor, Catherine Cesa-Luna, Lourival D. Possani & Verónica Quintero-Hernández. (2020) Recombinant C-Terminal Domains from Scorpine-like Peptides Inhibit the Plasmodium berghei Ookinete Development In Vitro. International Journal of Peptide Research and Therapeutics 27:1, pages 817-829.
Crossref
Molka Mokdadi, Yosser Zina Abdelkrim, Josette Banroques, Emmeline Huvelle, Rafeh Oualha, Hilal Yeter-Alat, Ikram Guizani, Mourad Barhoumi & N. Kyle Tanner. (2021) The In Silico Identification of Potential Members of the Ded1/DDX3 Subfamily of DEAD-Box RNA Helicases from the Protozoan Parasite Leishmania infantum and Their Analyses in Yeast. Genes 12:2, pages 212.
Crossref
Lisa U. Teufel, Leo A.B. Joosten & Jéssica Cristina dos Santos. (2021) Immunotherapeutic Potential of Interleukin-32 and Trained Immunity for Leishmaniasis Treatment. Trends in Parasitology 37:2, pages 130-141.
Crossref
Patrícia de Almeida Machado, Pollyanna Stephanie Gomes, Victor Midlej, Elaine Soares Coimbra & Herbert Leonel de Matos Guedes. (2021) PF-429242, a Subtilisin Inhibitor, Is Effective in vitro Against Leishmania infantum. Frontiers in Microbiology 12.
Crossref
FAZLUR RAHMAN, SHAMS TABREZ, RAHAT ALI, SAJJADUL KADIR AKAND, MOHAMMED A. ALAIDAROUS, MOHAMMED ALSAWEED, BADER MOHAMMED ALSHEHRI, SAEED BANAWAS, ABDUR RUB & ABDUL AZIZ BIN DUKHYIL. (2021) Identification of potential inhibitors for Sterol C-24 reductase of Leishmania donovani through virtual screening of natural compounds. BIOCELL 45:6, pages 1601-1610.
Crossref
Paul M. Selzer & Christian Epe. (2021) Antiparasitics in Animal Health: Quo Vadis?. Trends in Parasitology 37:1, pages 77-89.
Crossref
Jessica Carolina Martinez-Rico, Maira Elizabeth Herz-Ruelas & Jorge Ocampo-Candiani. (2021) Leishmaniasis cutánea y mucocutánea: abordaje clínico, diagnóstico y terapéutico. Piel 36:1, pages 22-30.
Crossref
Ozlem Ayse Tosyali, Adil Allahverdiyev, Melahat Bagirova, Emrah Sefik Abamor, Mehmet Aydogdu, Sahar Dinparvar, Tayfun Acar, Zeynep Mustafaeva & Serap Derman. (2021) Nano-co-delivery of lipophosphoglycan with soluble and autoclaved leishmania antigens into PLGA nanoparticles: Evaluation of in vitro and in vivo immunostimulatory effects against visceral leishmaniasis. Materials Science and Engineering: C 120, pages 111684.
Crossref
Douglas de Almeida Rocha, Lidiane Medeiros da Costa, Grasielle D'Ávila Caldas Pessoa & Marcos Takashi Obara. (2021) Methods for detecting insecticide resistance in sand flies: A systematic review. Acta Tropica 213, pages 105747.
Crossref
Simone Santiago de Carvalho Oliveira, Marta Helena Branquinha, Maria do Socorro Pires e Cruz, André Luis Souza dos Santos & Leandro Stefano Sangenito. 2021. Applications of Nanobiotechnology for Neglected Tropical Diseases. Applications of Nanobiotechnology for Neglected Tropical Diseases 291 327 .
Seyed Naser Emadi, Bahareh Abtahi-Naeini & Almudena Nuño González. 2020. Atlas of Dermatology, Dermatopathology and Venereology. Atlas of Dermatology, Dermatopathology and Venereology 1 31 .
Marija Stojković & Michael Lanzer. 2021. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 197 212 .
Douglas O. Escrivani, Gabriela C. Mattos, Bartira Rossi-Bergmann & Ariane J. Sousa-Batista. 2022. Antiprotozoal Drug Development and Delivery. Antiprotozoal Drug Development and Delivery 181 217 .
Dirlei Nico, Luciana Conde & Clarisa Beatriz Palatnik de Sousa. 2022. Antiprotozoal Drug Development and Delivery. Antiprotozoal Drug Development and Delivery 1 21 .
Paul Barrow, Jean Claude Dujardin, Nicolas Fasel, Alex D. Greenwood, Klaus Osterrieder, George Lomonossoff, Pier Luigi Fiori, Robert Atterbury, Matteo Rossi & Marco Lalle. (2020) Viruses of protozoan parasites and viral therapy: Is the time now right?. Virology Journal 17:1.
Crossref
Manar Madah, Shaden Haddad & Mays Khazem. (2020) Evaluation of the effect of Peganum harmala extracts on the in vitro viability of Leishmania tropica promastigotes in comparison to Glucantime. Journal of Parasitic Diseases 44:4, pages 858-863.
Crossref
Maria Beatriz Silva Costa & Camila Martins de Oliveira. (2020) Endophytic Fungi in the Fight Against Neglected Tropical Diseases. Mini-Reviews in Medicinal Chemistry 20:16, pages 1683-1693.
Crossref
Lais S. Morais, Renata G. Dusi, Daniel P. Demarque, Raquel L. Silva, Lorena C. Albernaz, Sônia N. Báo, Christian Merten, Luciana M. R. Antinarelli, Elaine S. Coimbra & Laila S. Espindola. (2020) Antileishmanial compounds from Connarus suberosus: Metabolomics, isolation and mechanism of action. PLOS ONE 15:11, pages e0241855.
Crossref
Ravi Ranjan, Pradeep Das & Saravanan Vijayakumar. (2020) Differentially modulated proteins associated with Leishmaniasis—a systematic review of in-vivo and in-vitro studies. Molecular Biology Reports 47:11, pages 9159-9178.
Crossref
Myla Lôbo de Souza, Lucas Amadeu Gonzaga da Costa, Emerson de Oliveira Silva, André Luiz Moreira Domingues de Sousa, Widson Michael dos Santos & Pedro José Rolim Neto. (2020) Recent strategies for the development of oral medicines for the treatment of visceral leishmaniasis. Drug Development Research 81:7, pages 803-814.
Crossref
Catalina Avendaño & Manuel Alfonso Patarroyo. (2020) Loop-Mediated Isothermal Amplification as Point-of-Care Diagnosis for Neglected Parasitic Infections. International Journal of Molecular Sciences 21:21, pages 7981.
Crossref
Jéssica Adriana Jesus, Thays Nicolli Fragoso da Silva, Eduardo Seiji Yamamoto, João Henrique G. Lago, Márcia Dalastra Laurenti & Luiz Felipe Domingues Passero. (2020) Ursolic Acid Potentializes Conventional Therapy in Experimental Leishmaniasis. Pathogens 9:10, pages 855.
Crossref
Yun Wu, Xiaojun Tian, Nan Song, Minjun Huang, Zhaoyong Wu, Shaogang Li, Nicholas R. Waterfield, Bin Zhan, Lei Wang & Guowei Yang. (2020) Application of Quantitative PCR in the Diagnosis and Evaluating Treatment Efficacy of Leishmaniasis. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Nelson Siukei Lam, Xinxin Long, Xin-zhuan Su & Fangli Lu. (2020) Melaleuca alternifolia (tea tree) oil and its monoterpene constituents in treating protozoan and helminthic infections. Biomedicine & Pharmacotherapy 130, pages 110624.
Crossref
Luciana Ângelo de Souza, Matheus Silva e Bastos, Joice de Melo Agripino, Thiago Souza Onofre, Lourdes Fanny Apaza Calla, Tino Heimburg, Ehab Ghazy, Theresa Bayer, Victor Hugo Ferraz da Silva, Paula Dutra Ribeiro, Leandro Licursi de Oliveira, Gustavo Costa Bressan, Márcia Rogéria de Almeida Lamêgo, Abelardo Silva-Júnior, Raphael de Souza Vasconcellos, Ana Márcia Suarez-Fontes, Juliana Almeida-Silva, Marcos André Vannier-Santos, Raymond Pierce, Wolfgang Sippl & Juliana Lopes Rangel Fietto. (2020) Histone deacetylases inhibitors as new potential drugs against Leishmania braziliensis, the main causative agent of new world tegumentary leishmaniasis. Biochemical Pharmacology 180, pages 114191.
Crossref
Satish Chandra Pandey, Awanish Kumar & Mukesh Samant. (2020) Genetically modified live attenuated vaccine: A potential strategy to combat visceral leishmaniasis. Parasite Immunology 42:9.
Crossref
Eduardo Seiji Yamamoto, Jéssica Adriana de Jesus, Adriana Bezerra-Souza, Juliana R. Brito, João Henrique G. Lago, Márcia Dalastra Laurenti & Luiz Felipe Domingues Passero. (2020) Tolnaftate inhibits ergosterol production and impacts cell viability of Leishmania sp.. Bioorganic Chemistry 102, pages 104056.
Crossref
Indira Singh Chauhan, Simran Marwa, G. Subba Rao & Neeloo Singh. (2020) Antiparasitic dibenzalacetone inhibits the GTPase activity of Rab6 protein of Leishmania donovani (LdRab6), a potential target for its antileishmanial effect. Parasitology Research 119:9, pages 2991-3003.
Crossref
Sumit Mukherjee, Samrat Moitra, Wei Xu, Veronica Hernandez & Kai Zhang. (2020) Sterol 14-α-demethylase is vital for mitochondrial functions and stress tolerance in Leishmania major. PLOS Pathogens 16:8, pages e1008810.
Crossref
Sibusiso Alven & Blessing Atim Aderibigbe. (2020) Nanoparticles Formulations of Artemisinin and Derivatives as Potential Therapeutics for the Treatment of Cancer, Leishmaniasis and Malaria. Pharmaceutics 12:8, pages 748.
Crossref
Aakriti Singh, Sandeep Sharma, Ganesh Yadagiri, Shabi Parvez, Ritika Gupta, Nitin Kumar Singhal, Nikhil Koratkar, Om Prakash Singh, Shyam Sundar, Vijayakumar Shanmugam & Shyam Lal Mudavath. (2020) Sensible graphene oxide differentiates macrophages and Leishmania : a bio-nano interplay in attenuating intracellular parasite . RSC Advances 10:46, pages 27502-27511.
Crossref
Aiman Saleh A. Mohammed, Weilu Tian, Youqin Zhang, Peng Peng, Fengshan Wang & Tianlu Li. (2020) Leishmania lipophosphoglycan components: A potent target for synthetic neoglycoproteins as a vaccine candidate for leishmaniasis. Carbohydrate Polymers 237, pages 116120.
Crossref
Muhammad Taha, Amyra Amat Sain, Muhammad Ali, El Hassane Anouar, Fazal Rahim, Nor Hadiani Ismail, Mohd Ilham Adenan, Syahrul Imran, Ahmed Al-Harrasi, Fasial Nawaz, Naveed Iqbal & Khalid Mohammed Khan. (2020) Synthesis of symmetrical bis-Schiff base-disulfide hybrids as highly effective anti-leishmanial agents. Bioorganic Chemistry 99, pages 103819.
Crossref
Fernando de Sá Ribeiro, Jéssica Barbosa de Jesus & Alessandra Mendonça Teles de Souza. (2020) Análise e caracterização de um promissor alvo terapêutico identificado em Leishmania spp. Revista Científica Multidisciplinar Núcleo do Conhecimento, pages 99-132.
Crossref
Fernando de Sá Ribeiro, Jéssica Barbosa de Jesus & Alessandra Mendonça Teles de Souza. (2020) Analysis and characterization of a promising therapeutic target identified in Leishmania spp. Revista Científica Multidisciplinar Núcleo do Conhecimento, pages 99-132.
Crossref
Ritika Kabra, Prajakta Ingale & Shailza Singh. (2020) Computationally designed synthetic peptides for transporter proteins imparts allostericity in Miltefosine resistant L. major . Biochemical Journal 477:10, pages 2007-2026.
Crossref
Justus Amuche Nweze, Emeka Innocent Nweze & Uwakwe Simon Onoja. (2020) Nutrition, malnutrition, and leishmaniasis. Nutrition 73, pages 110712.
Crossref
Grace Lovia Allotey-Babington, Seth Kwabena Amponsah, Thomas Nettey, Clement Sasu & Henry Nettey. (2020) Quinine Sulphate Microparticles as Treatment for Leishmaniasis. Journal of Tropical Medicine 2020, pages 1-9.
Crossref
Leopoldo F.M. Nascimento, Dayane Francisca Higino Miranda, Luana D. Moura, Flaviane A. Pinho, Guilherme Loureiro Werneck, Ricardo Khouri, Steven G. Reed, Malcolm S. Duthie, Aldina Barral, Manoel Barral-Netto & Maria S.P. Cruz. (2020) Allopurinol therapy provides long term clinical improvement, but additional immunotherapy is required for sustained parasite clearance, in L. infantum-infected dogs. Vaccine: X 4, pages 100048.
Crossref
Eleni Kontogiannidou, Thomas Meikopoulos, Christina Virgiliou, Nikolaos Bouropoulos, Helen Gika, Ioannis S. Vizirianakis, Anette Müllertz & Dimitrios G. Fatouros. (2020) Towards the development of Self-Nano-Emulsifying Drug Delivery Systems (SNEDDS) containing trimethyl chitosan for the oral delivery of amphotericin B: In vitro assessment and cytocompatibility studies. Journal of Drug Delivery Science and Technology 56, pages 101524.
Crossref
Samuel K. Kwofie, Emmanuel Broni, Bismark Dankwa, Kweku S. Enninful, Gabriel B. Kwarko, Louis Darko, Ravi Durvasula, Prakasha Kempaiah, Brijesh Rathi, Whelton A. Miller III, Abu Yaya & Michael D. Wilson. (2020) Outwitting an Old Neglected Nemesis: A Review on Leveraging Integrated Data-Driven Approaches to Aid in Unraveling of Leishmanicides of Therapeutic Potential. Current Topics in Medicinal Chemistry 20:5, pages 349-366.
Crossref
Archana Kumari & Rajesh K. Singh. (2020) Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight into the structure-activity relationship (SAR). Bioorganic Chemistry 96, pages 103578.
Crossref
Monika Bednarczyk, Henner Stege, Stephan Grabbe & Matthias Bros. (2020) β2 Integrins—Multi-Functional Leukocyte Receptors in Health and Disease. International Journal of Molecular Sciences 21:4, pages 1402.
Crossref
Shubhranshu Zutshi, Sunil Kumar, Aditya Sarode, Somenath Roy, Arup Sarkar & Bhaskar Saha. (2020) Leishmania major adenylate kinase immunization offers partial protection to a susceptible host . Parasite Immunology 42:2.
Crossref
Bahareh Vakili, Navid Nezafat, Bijan Zare, Nasrollah Erfani, Maryam Akbari, Younes Ghasemi, Mohammad Reza Rahbar & Gholam Reza Hatam. (2019) A new multi-epitope peptide vaccine induces immune responses and protection against Leishmania infantum in BALB/c mice. Medical Microbiology and Immunology 209:1, pages 69-79.
Crossref
Richard G. Wamai, Jorja Kahn, Jamie McGloin & Galen Ziaggi. (2020) Visceral leishmaniasis: a global overview. Journal of Global Health Science 2:1.
Crossref
Nilakshi Samaranayake. 2020. Molecular Advancements in Tropical Diseases Drug Discovery. Molecular Advancements in Tropical Diseases Drug Discovery 21 46 .
Marija Stojković & Michael Lanzer. 2020. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 1 15 .
Kiran Saleem, Zainab Khursheed, Christophe Hano, Iram Anjum & Sumaira Anjum. (2019) Applications of Nanomaterials in Leishmaniasis: A Focus on Recent Advances and Challenges. Nanomaterials 9:12, pages 1749.
Crossref

Displaying 200 of 229 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list